Company: VEEAW
Filing Date: 2025-01-15
Form Type: 424B3
Source: 0001213900-25-003892
Chunk: 44

Company: VEEA INC.
Filing Date: 2025-01-15
Form: 424B3
Chunk 44
---
 provisions that affect the way patent applications are prosecuted, redefine prior art, provide more efficient and cost-effective
avenues for competitors to challenge the validity of patents, and enable third-party submission of prior art to the USPTO during patent
prosecution and additional procedures to attack the validity of a patent at USPTO administered post-grant proceedings, including post-grant
review, inter partesreview, and derivation proceedings. Assuming that other requirements for patentability are met, prior to
March 2013, in the U.S., the first to invent the claimed invention was entitled to the patent, while outside the U.S., the first to file
a patent application was entitled to the patent. After March 2013, under the Leahy-Smith Act, the U.S. transitioned to a first-to-file
system in which, assuming that the other statutory requirements for patentability are met, the first inventor to file a patent application
will be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. As
such, the Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of Veea’s
patent applications and the enforcement or defense of patents to issue, all of which could have a material adverse effect on Veea’s
business, financial condition, results of operations and prospects.

In addition, the patent
positions of companies in the development and commercialization of biologics and pharmaceuticals are particularly uncertain. Recent U.S.
Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent
owners in certain situations.

Depending on future actions
by the U.S. Congress, the federal courts and the USPTO, the laws and regulations governing patents could change in unpredictable ways
that could have a material adverse effect on Veea’s patent rights and Veea’s ability to protect, defend and enforce Veea’s
patent rights in the future.

<div align='center'>19</div>

Veea may be subject to claims challenging the inventorship or ownership of Veea’s patent and other intellectual property rights.

Veea or Veea’s licensors
may be subject to claims that former employees, collaborators or other third parties have an interest in Veea’s owned or in-licensed
patent rights, trade secrets or other intellectual property as an inventor or co-inventor. For example, Veea or Veea’s licensors
may have inventorship disputes arise from conflicting obligations